AUTL Autolus Therapeutics plc Stock Quote

publish chart | save to portfolio | create alert

Settings

AUTL [NASD]

Autolus Therapeutics plc

Healthcare | Biotechnology | United Kingdom

statements

Index	-	P/E	-	EPS (ttm)	-2.74	Insider Own	31.86%	Shs Outstand	52.04M	Perf Week	-14.35%
Market Cap	553.34M	Forward P/E	-	EPS next Y	-3.16	Insider Trans	0.00%	Shs Float	8.82M	Perf Month	-15.70%
Income	-130.10M	PEG	-	EPS next Q	-0.75	Inst Own	25.70%	Short Float	8.57%	Perf Quarter	-37.35%
Sales	1.20M	P/S	461.12	EPS this Y	-448.30%	Inst Trans	-11.38%	Short Ratio	10.59	Perf Half Y	-19.78%
Book/sh	4.98	P/B	1.93	EPS next Y	-16.60%	ROA	-41.10%	Target Price	-	Perf Year	-32.75%
Cash/sh	3.68	P/C	2.61	EPS next 5Y	-	ROE	-48.60%	52W Range	3.00 - 17.19	Perf YTD	-27.20%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-51.40%	52W High	-44.10%	Beta	-
Dividend %	-	Quick Ratio	9.10	Sales past 5Y	-	Gross Margin	-	52W Low	220.33%	ATR	0.78
Employees	290	Current Ratio	9.10	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	37.06	Volatility	8.26% 7.79%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	5.70%	Profit Margin	-	Rel Volume	2.16	Prev Close	10.58
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 05 BMO	Payout	-	Avg Volume	71.44K	Price	9.61
Recom	1.80	SMA20	-12.77%	SMA50	-18.32%	SMA200	-17.53%	Volume	154,118	Change	-9.17%

Jul-31-20

Initiated

JP Morgan

Overweight

Jul-22-20

Initiated

SunTrust

Buy

$38

Apr-22-20

Initiated

Mizuho

Buy

$18

Sep-23-19

Initiated

Needham

Buy

$26

May-17-19

Reiterated

H.C. Wainwright

Buy

$45 → $41

Oct-24-18

Initiated

H.C. Wainwright

Buy

$45

Nov-17-20 07:00AM	Autolus Therapeutics to host Investor Conference Call to discuss AUTO1 and AUTO3 data presented at ASH and to participate in the Jefferies Virtual London Healthcare Conference GlobeNewswire
Nov-07-20 07:47AM	Earnings Beat: Autolus Therapeutics plc (NASDAQ:AUTL) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts Simply Wall St.
Nov-06-20 05:30AM	News Flash: Analysts Just Made A Meaningful Upgrade To Their Autolus Therapeutics plc (NASDAQ:AUTL) Forecasts Simply Wall St. -8.83%
Nov-05-20 07:00AM	Autolus Therapeutics Reports Third Quarter 2020 Financial Results and Operational Progress GlobeNewswire
Oct-30-20 07:00AM	Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5 GlobeNewswire -5.34%
Sep-18-20 03:05AM	Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO Virtual Congress 2020 GlobeNewswire
Sep-08-20 07:00AM	Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through September GlobeNewswire
Sep-01-20 07:48AM	Can You Imagine How Autolus Therapeutics' (NASDAQ:AUTL) Shareholders Feel About The 47% Share Price Increase? Simply Wall St.
Aug-06-20 07:00AM	Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational Progress GlobeNewswire +7.32%
Aug-05-20 10:05AM	J.P. Morgan: These 2 Healthcare Stocks Are Must-Watch Names TipRanks
Aug-04-20 07:00AM	Autolus announces changes to its Board and Management Team GlobeNewswire +5.15%
Jul-30-20 07:00AM	Autolus Therapeutics to Report Second Quarter 2020 Financial Results and Host Conference Call on August 6 GlobeNewswire
Jul-02-20 04:39PM	Hedge Funds Are Buying Autolus Therapeutics plc (AUTL) Insider Monkey -6.88%
Jun-24-20 09:32AM	Moving Average Crossover Alert: Autolus Therapeutics Zacks
Jun-22-20 07:00AM	Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual Meeting GlobeNewswire +13.42%
Jun-19-20 11:30AM	Is Autolus Therapeutics PLC Sponsored (AUTL) Stock Outpacing Its Medical Peers This Year? Zacks
Jun-12-20 02:30AM	Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual Congress GlobeNewswire
Jun-08-20 05:00PM	Autolus Therapeutics reschedules its investor EHA conference call GlobeNewswire
Jun-03-20 06:28AM	Industry Analysts Just Upgraded Their Autolus Therapeutics plc (NASDAQ:AUTL) Revenue Forecasts By -3.3% Simply Wall St.
Jun-02-20 08:07AM	Autolus Therapeutics' Shares March Higher, Can It Continue? Zacks +6.76%
May-29-20 07:37AM	Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ASCO20 Virtual Scientific Program GlobeNewswire +10.50%
May-26-20 07:00AM	Autolus Therapeutics to host Investor Conference Calls through June GlobeNewswire
May-22-20 07:00AM	Autolus Notice of Annual General Meeting (AGM) on Thursday, June 18, 2020 GlobeNewswire
May-15-20 11:20AM	Autolus Therapeutics to Present New Data at the Virtual 2020 AACR Annual Meeting GlobeNewswire
07:00AM	Autolus Therapeutics to Present New Data on AUTO1 and AUTO3 at the 2020 EHA Annual Meeting GlobeNewswire
May-14-20 07:00AM	Autolus Therapeutics to Present New Data on AUTO3 during the ASCO20 Virtual Scientific Program GlobeNewswire
May-13-20 09:27AM	Is Autolus Therapeutics (AUTL) Stock a Solid Choice Right Now? Zacks
May-12-20 12:00PM	Autolus Therapeutics PLC Sponsored ADR (AUTL) Upgraded to Strong Buy: What Does It Mean for the Stock? Zacks
10:52AM	Will Autolus Therapeutics Continue to Surge Higher? Zacks
May-10-20 08:26AM	Analyst Estimates: Here's What Brokers Think Of Autolus Therapeutics plc (NASDAQ:AUTL) After Its First-Quarter Report Simply Wall St.
May-09-20 11:01PM	Autolus Therapeutics Plc (AUTL) Q1 2020 Earnings Call Transcript Motley Fool
08:26AM	Is Autolus Therapeutics (NASDAQ:AUTL) In A Good Position To Deliver On Growth Plans? Simply Wall St.
May-07-20 08:06AM	Autolus Therapeutics: Q1 Earnings Insights Benzinga
07:00AM	Autolus Therapeutics Reports First Quarter 2020 Financial Results and Operational Progress GlobeNewswire
May-01-20 07:00AM	Autolus Therapeutics to Report First Quarter 2020 Financial Results and Host Conference Call on May 7 GlobeNewswire
Apr-16-20 07:00AM	Autolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic Leukemia GlobeNewswire
Mar-03-20 07:07AM	Autolus Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Operational Progress GlobeNewswire +6.07%
Feb-25-20 07:00AM	Autolus Therapeutics to Present at the Cowen 40th Annual Health Care Conference GlobeNewswire -8.06%
Feb-24-20 07:00AM	Autolus Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results and Host Conference Call on March 3 GlobeNewswire -5.25%
Jan-30-20 07:00AM	Autolus Therapeutics Presents Encouraging Additional Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers GlobeNewswire
Jan-27-20 04:00PM	Autolus Announces Closing of Public Offering GlobeNewswire
07:00AM	Autolus Chief Scientific Officer, Dr Martin Pulé, to give Keynote Lecture at the EHA-EBMT 2nd European CAR T Cell Meeting GlobeNewswire
Jan-22-20 09:41PM	Autolus Announces Pricing of Public Offering GlobeNewswire
04:41PM	Autolus Announces Proposed Public Offering in the United States GlobeNewswire
Jan-13-20 07:00AM	Autolus Therapeutics to provide outlook for 2020 at the 38th Annual J.P. Morgan Conference GlobeNewswire
Jan-08-20 11:48AM	Wall Street Recommends Catching These 2 Falling Knives GuruFocus.com
Dec-20-19 06:30AM	Autolus Therapeutics to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-18-19 07:59AM	5 Beaten-Down Biotech Stocks Set to Rebound in 2020 Zacks
Dec-14-19 07:47PM	Is Autolus Therapeutics plc (AUTL) A Good Stock To Buy? Insider Monkey
Dec-08-19 09:15AM	Autolus Therapeutics Announces New Data Showcasing Clinical Progress of AUTO3 in B Cell Malignancies GlobeNewswire
Dec-07-19 02:00PM	Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood Cancers GlobeNewswire
08:35AM	The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling Benzinga
Dec-05-19 04:30PM	Autolus Therapeutics Announces Conference Call to Review Clinical Data for Programmed T Cell Therapy Pipeline Presented at the 2019 ASH Annual Meeting GlobeNewswire -7.16%
Nov-27-19 07:03AM	Will Autolus Continue to Surge Higher? Zacks
Nov-18-19 04:52AM	What Kind Of Shareholder Appears On The Autolus Therapeutics plc's (NASDAQ:AUTL) Shareholder Register? Simply Wall St.
Nov-13-19 04:02PM	Autolus Therapeutics to Present at the Jefferies 2019 London Healthcare Conference GlobeNewswire
06:30AM	Autolus Therapeutics and Noile-Immune Announce Licensing Agreement GlobeNewswire
Nov-09-19 07:00AM	Autolus Therapeutics Presents Preclinical Data on AUT06NG at the SITC Annual Meeting GlobeNewswire
Nov-07-19 07:06AM	Autolus Therapeutics Reports Third Quarter 2019 Financial Results and Operational Progress GlobeNewswire
Nov-06-19 09:24AM	Autolus Therapeutics to Present New Data on Its Advanced Programmed T Cell Therapies at the 61st ASH Annual Meeting GlobeNewswire -8.75%
Nov-05-19 09:35AM	Autolus Therapeutics to Present Preclinical Data on AUT06NG at the SITC Annual Meeting GlobeNewswire +10.69%
09:10AM	Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO1 for Treatment of Acute Lymphoblastic Leukemia GlobeNewswire
Oct-31-19 06:30AM	Autolus Therapeutics to Report Third Quarter 2019 Financial Results and Host Conference Call on November 7 GlobeNewswire
Oct-30-19 07:01PM	Is Autolus Therapeutics plc (AUTL) A Good Stock To Buy? Insider Monkey
Oct-08-19 08:00AM	Autolus Announces Changes to Executive Leadership Team GlobeNewswire
Oct-03-19 09:08AM	Autolus Announces Data Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting GlobeNewswire
Sep-19-19 08:53AM	Before You Invest In Autolus Therapeutics plc (NASDAQ:AUTL), Consider This Simply Wall St.
Sep-16-19 10:34AM	Czech billionaire Kellner's PPF Group expands in biotech with Autolus stake Reuters
Sep-03-19 02:00AM	Autolus Announces Publication in Nature Medicine of Data Supporting the Development of AUTO1 for Treatment of Patients with ALL GlobeNewswire
Aug-28-19 04:05PM	Autolus Therapeutics to Participate in Upcoming Investor Conferences in September GlobeNewswire -5.28%
Aug-09-19 02:24AM	Autolus Therapeutics Plc (AUTL) Q2 2019 Earnings Call Transcript Motley Fool -13.05%
Aug-08-19 07:49AM	Autolus Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress GlobeNewswire -12.14%
Aug-02-19 09:06AM	Autolus Therapeutics to Report Second Quarter 2019 Financial Results and Host Conference Call on August 8 GlobeNewswire
Jul-16-19 10:31AM	Did You Manage To Avoid Autolus Therapeutics's (NASDAQ:AUTL) 26% Share Price Drop? Simply Wall St.
Jun-19-19 08:40AM	Autolus Therapeutics (AUTL) in Focus: Stock Moves 8.5% Higher Zacks
May-28-19 04:55PM	Autolus Therapeutics to Participate in Upcoming Investor Conferences in June GlobeNewswire
May-14-19 06:30AM	Autolus Therapeutics Reports First Quarter 2019 Financial Results and Operational Progress GlobeNewswire +6.48%
06:30AM	Autolus Therapeutics Plc to Host Earnings Call ACCESSWIRE
May-07-19 04:05PM	Autolus Therapeutics to Report First Quarter 2019 Financial Results and Host Conference Call on May 14 GlobeNewswire
Apr-29-19 02:52PM	Is Autolus Therapeutics plc (AUTL) A Good Stock To Buy? Insider Monkey
Apr-23-19 07:49AM	Autolus Therapeutics Receives FDA Orphan Drug Designation for AUTO3 for Treatment of Acute Lymphoblastic Leukemia GlobeNewswire
Apr-15-19 04:02PM	Autolus Announces Closing of Public Offering and Full Exercise of Underwriters Option to Purchase Additional American Depositary Shares GlobeNewswire +7.20%
03:29PM	What Kind Of Shareholder Owns Most Autolus Therapeutics plc (NASDAQ:AUTL) Stock? Simply Wall St.
Apr-12-19 08:50AM	Autolus Therapeutics (AUTL) Catches Eye: Stock Jumps 5.6% Zacks
Apr-10-19 09:19PM	Autolus Announces Pricing of Public Offering GlobeNewswire -9.16%
Apr-08-19 04:40PM	Autolus Announces Proposed Public Offering in the United States GlobeNewswire
Apr-01-19 02:29PM	Arix Bioscience plc - Autolus Presents Initial AUTO1 Data at AACR PR Newswire
01:05PM	Initial Results from Autolus Therapeutics ALLCAR19 Phase 1/2 Trial in Adult Acute Lymphoblastic Leukemia Presented at the AACR Annual Meeting GlobeNewswire
Mar-29-19 04:05PM	Arix Bioscience plc - Autolus Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019 PR Newswire
04:03PM	Autolus Therapeutics Announces Conference Call to Discuss AUTO1 ALLCAR19 Data Presentation at the AACR Annual Meeting 2019 GlobeNewswire
Mar-26-19 06:00AM	Autolus Therapeutics Unveils Expanded Next Generation Technology and Pipeline and Provides Key Update on AUTO3 Program in Pediatric ALL at R&D Day GlobeNewswire +7.89%
Mar-07-19 04:05PM	Autolus Therapeutics to Host R&D Day on March 26, 2019 GlobeNewswire
Mar-04-19 04:05PM	Autolus Therapeutics to Present at the Cowen and Company 39th Annual Healthcare Conference GlobeNewswire
06:30AM	Autolus Therapeutics to Present New Data on AUTO1 at the American Association of Cancer Research (AACR) Annual Meeting 2019 GlobeNewswire
Feb-25-19 06:15AM	Vineti announces strategic partnership with Autolus Therapeutics to support delivery of novel T cell therapies GlobeNewswire
06:00AM	Autolus Therapeutics Reports Financial and Operational Results for the Transition Period from October 1 to December 31, 2018 PR Newswire
Feb-21-19 06:30AM	Autolus Therapeutics to Announce Financial Results for the Transition Period from October 1, 2018 to December 31, 2018 and Host Conference Call on February 25, 2019 PR Newswire
Feb-19-19 09:08AM	Arix Bioscience plc: Autolus Announces Updated Results From CARPALL Trial PR Newswire
06:30AM	Autolus Therapeutics Announces Updated Results from Ongoing CARPALL Trial of Pediatric Acute Lymphoblastic Leukemia Presented at the EHA 1st European CAR T Cell Meeting in Paris PR Newswire
Jan-16-19 09:05AM	Alexandria Fully Leases New Built-to-Suit Facility to Autolus Zacks

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of hematological malignancies and solid tumors. The company is developing AUTO1 and AUTO3 for B cell malignancies; AUTO2 for the treatment of multiple myeloma; AUTO4 and AUTO 5 for T cell lymphoma; and AUTO6 and AUTO7 to treat solid tumors. The company was founded in 2014 and is headquartered in London, the United Kingdom.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience